Navigation Links
ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO

2/3 clinical trials for chronic myeloid leukemia (CML) and Quinamed(R) is in phase 2 clinical development for prostate, breast and ovarian cancers. The company has a significant portfolio of anti-cancer, diabetes and obesity programs, several of which have been partnered with international pharmaceutical companies. ChemGenex currently trades on the Australian Stock Exchange under the symbol "CXS" and on NASDAQ under the symbol "CXSP".

Safe Harbor Statement

Certain statements made herein that use the words "estimate", "project", "intend", "expect", "believe", and similar expressions are intended to identify forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties which could cause the actual results, performance or achievements of the company to be materially different from those which may be expressed or implied by such statements, including, among others, risks or uncertainties associated with the development of the company's technology, the ability to successfully market products in the clinical pipeline, the ability to advance promising therapeutics through clinical trials, the ability to establish our fully integrated technologies, the ability to enter into additional collaborations and strategic alliances and expand current collaborations and obtain milestone payments, the suitability of internally discovered genes for drug development, the ability of the company to meet its financial requirements, the ability of the company to protect its proprietary technology, potential limitations on the company's technology, the market for the company's products, government regulation in Australia and the United States, changes in tax and other laws, changes in competition and the loss of key personnel. These statements are based on our management's current expectations and are subject to a number of uncertainties that could chan
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:5/17/2013)...  Lakeland Industries, Inc. (NASDAQ: LAKE ), ... healthcare and to first responders on the federal, state ... the fiscal 2013 fourth quarter and year ended January ... market close and will conduct a conference call on ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call ...
(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   Shareholder ... purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has ... the District of Massachusetts .  The ... violated the Securities Exchange Act of 1934 (the "Exchange ... (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
(Date:5/18/2013)... Orlando, FL (May 18, 2013) The use ... for a colonoscopy, according to new research presented ... process, which begins days in advance of the ... preparation medication to be taken at strict intervals. ... for doctors to see cancer and precancerous polyps ...
(Date:5/18/2013)... of coffee is associated with a reduced risk ... disease, Mayo Clinic research shows. The findings were ... conference in Orlando, Fla. , PSC is ... results in inflammation and subsequent fibrosis that can ... and biliary cancer. , "While rare, PSC has ...
(Date:5/18/2013)... Hayden, ID (PRWEB) May 18, 2013 ... needs when it comes to safety and comfort ... these requirements and provides clients with an effective ... System®. This is an integrated, turnkey communications ... of care, while allowing residents independence and privacy. ...
(Date:5/18/2013)... Utah (PRWEB) May 18, 2013 ... on insurance agents’ role in Marketplaces . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... Health and Human Services (HHS) recently released a ...
(Date:5/18/2013)... Springs, FL (PRWEB) May 18, 2013 The ... dedicated to the special places we call home. These are ... on maps. They are the locations where the people are ... first-rate show takes viewers off the highways and shares the ... best of both nations with an American sports and film ...
Breaking Medicine News(10 mins):Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2
... the seat of the Polish government Friday in support of ... of the building in a two-week pay protest. ... Silesian coal belt, brandished banners reading, "We want a decent ... ,Ringed by riot police, the demonstrators mingled with ...
... more likely to suffer heart attacks, according to a ... Bhopal and Colin Fischbacher at the University of Edinburgh, however, ... in comparison to their non-Asian countrymen. ,As part ... groups from the 2001 Census to Scottish hospital discharge and ...
... Britney Spears has openly confessed that she had sex with former ... until she was married. ,"I've only slept with ... into my relationship with Justin, and I thought he was the ... a magazine The most painful thing I have ever experienced ...
... the web are all pass, for the latest way to bag ... ,This new trend is a blessing for many singleton smokers ... a cigarette. ,This blend of smoking and flirting developed ... introduced, reports The Sun. ,The Irish were the first ...
... identified one unifying principle that could explain how a range ... for the cause of depression has implicated so many suspects ... condition remains an enigma. ,They found that ... treatment in the end appear to funnel through a single ...
... Saturday announced new measures aimed at curbing an epidemic ... prove elusive . ,China plans to set ... by the end of the year and to implement ... was quoted by the official Xinhua news agency as ...
Cached Medicine News:Health News:Trade Unionists Join Polish Nurses' Protest 2Health News:Brain Pathway for Depression Revealed 2Health News:Brain Pathway for Depression Revealed 3Health News:Top China Official Pessimistic on Fixing Food Safety Woes 2
A "doughy" type of bone cement intended for manual application....
... The Videoscopes provide superior image quality ... to the camera head with a ... ensures more light at the operative ... optimum image clarity and reliability.,The Videoscopes ...
... a wide range of innovative features, including ... Control (U.S. Patent #4,684,227). Stereopsis is maximized ... Heine's unique Diffuser aperture absorbs only 30% ... and simplifying difficult examinations. A newly incorporated ...
... 3-wire patient cable and 4 ... of the unit. 3-step procedure enabling ... 8 or 12 lead ECG through ... position. Records 2.5 seconds per lead ...
Medicine Products: